#Dario Amodei
2 articles found
Anthropic CEO Dario Amodei says AI can accelerate drug discovery
Pharmaceutical companies are increasingly integrating artificial intelligence into drug discovery processes to reduce development timelines. Meanwhile, artificial intelligence firms like Anthropic are forming partnerships and seeking acquisitions in the sector.
November 20, 2026
Read More →
Anthropic raises US$81 billion in record IPO valuing firm at US$1.5 trillion
Anthropic has completed a record US$81 billion initial public offering at Nasdaq in New York, valuing the artificial intelligence company at about US$1.5 trillion. Chief executive Dario Amodei stated the firm would not bend to business or political pressure.